摘要
目的:开发一种姜黄素药物共晶,以改善姜黄素生物利用度低、成药性差的问题。方法:采用溶剂结晶法,制备姜黄素-赖氨酸共晶,并培养得到a、b两种晶型。通过元素分析、差示扫描量热分析、X射线衍射法分别对其进行表征。测定上述两种晶型的溶解曲线,同姜黄素作对比。结果:姜黄素与赖氨酸按照1∶1的化学计量比结合,形成共晶,得到的共晶溶解性能明显优于姜黄素。结论:姜黄素-赖氨酸共晶具有良好的成药性可作为新的化学实体进行后续开发。
Objective : To develop a new cocrystal form to improve bioavailability and druggability of curcumin. Methods: Solvent crystallization was used to prepare curcumin-lysine cocrystal, and two crystal forms ( a and b) were obtained. The two cocrystal forms were characterized by elemental analysis, differential scanning calorimetry and X-ray diffraction. The dissolution profiles of the two crystal forms were detected and compared with that of curcumin. Results: Curcumin combined with lysine at a stoichiometry of 1 : 1 to form the cocrystal with much better solubility than curcumin. Conclusion: Curcumin-lysine cocrystal has ideal druggability, which means the cocrystal can be a new chemical entity used for subsequent development.
作者
徐辉
张方坤
迟宗良
蔡宝昌
Xu Hui Zhang Fangkun Chi Zongliang Cai Baoehang(Gulou Street Community Health Service Center in Haishu District, Zhejiang Ningbo 315000, China Nanjing Haichang Chinese Medicine Group Co. Ltd. Jiangsu Key Laboratory of Chinese Medi- cine Processing)
出处
《中国药师》
CAS
2017年第2期208-212,共5页
China Pharmacist
基金
江苏省自然科学基金项目(编号:BK20141094)
关键词
姜黄素
共晶
赖氨酸
溶解曲线
Curcumin
Cocrystal
Lysine
Dissolution profiles